[Featured Stocks] SK Chemicals and Jin Matrix Related to AstraZeneca Rise↑

[Asia Economy Reporter Minji Lee] Shares related to SK Chemicals and Jin Matrix are rising following news that a COVID-19 vaccine candidate developed by the British multinational pharmaceutical company AstraZeneca showed a strong immune response in trials involving elderly subjects.

At 9:14 a.m. on the 27th in the KOSPI market, SK Chemicals was trading at 347,500 KRW, up 4.04% from the previous session. In the KOSDAQ market, Jin Matrix was trading at 16,950 KRW, up 3.99%.

AstraZeneca logo

SK Chemicals and Jin Matrix are classified as AstraZeneca-related stocks. SK Chemicals is the parent company of SK Bioscience, which has a contract with AstraZeneca for contract manufacturing organization (CMO) of the COVID-19 vaccine. Jin Matrix is known to hold shares in SK Discovery, which has a stake in SK Chemicals, and in Vaxcyte, a spin-off from the University of Oxford.

On the 26th (local time), AstraZeneca announced that clinical trials conducted with the University of Oxford on the COVID-19 vaccine candidate confirmed an effective immune response in trials involving elderly individuals, who are vulnerable to COVID-19.